New York Presbyterian Columbia Irving Comprehensive Cancer Center

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Breast Diseases, Breast Neoplasms

Studies at this site

• Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast — Running, not enrolling